Pre-earnings options volume in Soleno Therapeutics (SLNO) is 2.6x normal with calls leading puts 3:1. Implied volatility suggests the market is anticipating a move near 15.9%, or $10.45, after results are released. Median move over the past eight quarters is 3.1%.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SLNO:
- SLNO Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- Soleno not preannouncing Q3 sales ‘disappointing,’ says STAT’s Feuerstein
- Soleno Therapeutics rumor highlighted in Betaville alert
- Soleno Therapeutics Appoints Mark Hahn to Board
- Soleno Therapeutics appoints Hahn to its board of directors